News

U.S. Task Force: No PSA Testing for Healthy Men


 

FROM A LITERATURE REVIEW BY THE U.S. PREVENTIVE SERVICES TASK FORCE

Treatment of approximately three men with prostatectomy or seven men with radiation therapy instead of watchful waiting would each result in one additional case of erectile dysfunction, the review revealed. Similarly, treatment of five men with prostatectomy instead of watchful waiting would result in one additional case of urinary incontinence.

"Everybody wants to believe that PSA screening saved their lives. Well, it may work for some men, but the problem is we cannot tell which men it works for," Dr. Lichtenfeld said. "And it clearly does not work well enough for enough men that it justifies a uniform recommendation that requires men to be screened."

"I don’t believe PSA screening is going to go away," he said. "But I do believe doctors and patients are going to have more appropriate discussions about the potential value." For more of Dr. Lichtenfeld’s perspective, see his blog post.

Dr. Lichtenfeld had no relevant financial disclosures. Dr. Chou received a research grant and travel support from the Agency for Healthcare Research and Quality, which funded the systematic review study.

Pages

Recommended Reading

Radical Prostatectomy Continues to Cut Mortality After 15 Years
MDedge Hematology and Oncology
Two-Tiered Prostate Cancer Surveillance May Curb Overtreatment
MDedge Hematology and Oncology
In the Pipeline: Cabozantinib Shown to Control Tumors and Bone Metastases
MDedge Hematology and Oncology
Abiraterone Prolongs Survival in Castration-Resistant Prostate Cancer
MDedge Hematology and Oncology
PIVOT Trial: No Overall Benefit to Radical Prostatectomy for Localized Prostate Cancer
MDedge Hematology and Oncology
Positive Data on Alpharadin Could Accelerate Filing Timeline
MDedge Hematology and Oncology
FDA Adds Warnings About High-Grade Prostate Cancer to BPH Drug Labels
MDedge Hematology and Oncology
Short-Term ADT with Radiotherapy Ups Prostate Cancer Survival
MDedge Hematology and Oncology
Factors Predict Erectile Function After Prostate Cancer Therapy
MDedge Hematology and Oncology
FDA Approves Tadalafil for Benign Prostatic Hyperplasia
MDedge Hematology and Oncology